Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

TB-500 Research Endurance Considerations — Comparison

Primary Mechanism Angiogenesis via actin sequestration; promotes capillary density and tissue repair Increases red blood cell production; elevates oxygen-carrying capacity Enhances mitochondrial biogenesis and oxidative phosphorylation efficiency TB-500 builds

This comparison does not assign a generated winner or score.

  • Primary Mechanism
  • Angiogenesis via actin sequestration; promotes capillary density and tissue repair
  • Increases red blood cell production; elevates oxygen-carrying capacity
  • Enhances mitochondrial biogenesis and oxidative phosphorylation efficiency
  • TB-500 builds vascular infrastructure; EPO increases oxygen transport; MOTS-c optimises cellular energy production. Different mechanisms, different timelines
  • Timeline to Measurable Effect
  • 21–28 days for structural changes; 5–8 weeks for performance gains
  • 2–4 weeks for RBC elevation; immediate haematocrit increase
  • 2–3 weeks for mitochondrial density markers; 4–6 weeks for aerobic capacity change
  • TB-500 is the slowest to produce functional outcomes but targets foundational vascular capacity
  • Dose Frequency Requirement
  • Twice weekly for sustained tissue presence (plasma half-life ~10 hours)
  • Once weekly; longer half-life (6–8 hours in circulation but sustained effect via bone marrow stimulation)
  • Daily or every-other-day; short half-life (~30 minutes in plasma)
  • TB-500 requires consistent administration but less frequent than mitochondrial peptides
  • Performance Metric Most Affected
  • Time-to-exhaustion in sustained aerobic work; improved recovery between high-volume sessions
  • VO2 max elevation; increased oxygen delivery at maximal intensity
  • Lactate threshold improvement; enhanced fat oxidation at submaximal intensities
  • Each targets a different physiological bottleneck. TB-500 addresses tissue-level oxygen perfusion, not systemic transport or metabolic efficiency
  • Training Dependency
  • Requires concurrent training stress to direct vascular growth; minimal effect in sedentary subjects
  • Independent of training. RBC production occurs regardless of activity level
  • Moderate training dependency; effect amplified by mitochondrial stress signals from exercise
  • TB-500 is the most training-dependent. It amplifies adaptation, it doesn't create it
  • TB-500 research endurance considerations differ fundamentally from other endurance-related compounds because the mechanism operates at the tissue structure level, not the metabolic or haematologic level. Comparing TB-500 to EPO is comparing infrastructure expansion to resource availability. Both can improve endurance, but through entirely separate pathways.
More references

Related material